Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock (AQST)
CUSIP: 03843E104
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 43,378,481
- Total 13F value
- $154,428,036
- Share change
- -3,458,097
- Put/Call ratio
- 29%
- SEC-reported price per share
- $3.56
- Number of holders
- 113
- Value change
- -$13,648,629
- Number of buys
- 59
- Number of sells
- 53
- Shares outstanding
- 124,885,109
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
113
Top holders
10
AQST full security history
Ownership snapshot
Full 13F holder table
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Douglas K. Bratton
Disclosed value leader
Bratton Capital Managemen...
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
3/4/5
13F
Lead comparable stake: 11%
13D/G row: Douglas K. Bratton
Showing 1-6 of 15 holder rows.
Quick read
Douglas K. Bratton leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Douglas K. Bratton's linked filing trail.
Comparable ownership
Top 5
Douglas K. Bratton
11%
Venrock Healthcare Capital Partne...
2.9%
Bratton Capital Management, L.P.
7.9%
BlackRock, Inc.
4.7%
Venrock Adviser, LLC
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Douglas K. Bratton |
13D/G
3/4/5
BRATTON DOUGLAS K · 10%+ Owner
|
11%
|
$28,720,687
10,077,434 shares
|
$0 | 31 Dec 2024 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
2.9%
|
$7,494,890
2,629,786 shares
|
$0 | 31 Dec 2024 |
| Bratton Capital Management, L.P. |
13F
Company
|
7.9%
|
$48,858,571
9,810,958 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
4.7%
|
$28,998,924
5,823,077 shares
|
— | 30 Sep 2024 |
| Venrock Adviser, LLC |
13F
Company
|
4.4%
|
$27,666,664
5,555,555 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$21,233,703
4,263,796 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
113
Shares
43,378,481
Rows available
113
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
116
Q4 2024 holders
113
Holder diff
-3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|